SavaravsThermo Fisher Scientific

SVRA and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$669.54

Value $249B

-2.79%
TMO's page

Savara (SVRA) has a market value of $940M and Thermo Fisher Scientific (TMO) $249B. Over the last year, with dividends, SVRA moved -7.4% and TMO +17.1%. Dividend yield: SVRA none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SVRA$940M

    TMO$249B

    TMO is 265 times SVRA

  • Revenue, 12 months

    SVRA–

    TMO$47.4B

  • Net income, 12 months

    SVRA-$153M

    TMO$7.1B

  • Operating margin

    SVRA–

    TMO17.9%

  • ROIC

    SVRA-41.9%

    TMO8.2%

    50.1 points apart

  • P/E

    SVRA–

    TMO35.2

  • Dividend yield

    SVRA0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    SVRA+294.4%

    TMO+6.8%

    287.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SVRA+294.4%

TMO+6.8%

20040060020222023202420252026
Returns by period
PeriodSVRAWith dividendsTMOWith dividends
1 year since November 19, 2025-7.4%Price -7.4%+17.1%Price +16.7%
3 years since November 20, 2023+13.6%+4.3% a yearPrice +13.6%+44.1%+13.0% a yearPrice +42.7%
5 years since November 19, 2021+294.4%+31.6% a yearPrice +294.4%+6.8%+1.3% a yearPrice +5.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SVRASavaraTMOThermo Fisher Scientific

Valuation

SVRATMO
Valuation
Price$4.26$669.54
Market value$940M$249B
Enterprise value (EV)$840M$284B
P/E–35.2
P/E, 5-year median–32.7
P/B8.74.5
EV/EBIT–33.5
Free cash flow yield–3.1%

Results and growth

SVRATMO
Results and growth
Revenue, 12 months–$47.4B
Net income, 12 months-$153M$7.1B
Free cash flow, 12 months-$131M$7.6B
Earnings per share, 12 months-$0.61$18.96
Revenue growth, year on year–3.9%
Revenue growth a year, past+36.6%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

SVRATMO
Margins and returns on capital
Gross margin––
Operating margin–17.9%
Net margin–14.9%
ROIC-41.9%8.2%
ROE-105.3%13.4%

Balance sheet

SVRATMO
Balance sheet
Cash$130M$6.1B
Total debt$32M$41.4B
Net debt / EBITDA–3.7
Interest cover–5.5×

Dividends and buybacks

SVRATMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SVRA or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Savara or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($249B) is about 264.6 times Savara ($940M), at today's prices.

How did SVRA and TMO stock do over the last 5 years?

Since November 19, 2021, SVRA's price moved +294.4% and TMO's +5.3%. With dividends: SVRA +294.4% (+31.6% a year), TMO +6.8% (+1.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, SVRA or TMO?

The dividend yield at today's price is none for Savara and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which is the better investment, Savara or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.